Literature DB >> 18326881

Successful pre-transplant management of a patient with anti-factor H autoantibodies-associated haemolytic uraemic syndrome.

Theresa Kwon1, Marie-Agnes Dragon-Durey, Marie-Alice Macher, Veronique Baudouin, Anne Maisin, Michel Peuchmaur, Veronique Fremeaux-Bacchi, Chantal Loirat.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18326881     DOI： 10.1093/ndt/gfn063

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  29 in total

1.  A case of atypical hemolytic uremic syndrome due to anti-factor H antibody in a patient presenting with a factor XII deficiency identified two novel mutations.

Authors:  Eiji Matsukuma; Yoshimitsu Gotoh; Yoshiyuki Kuroyanagi; Takuji Yamada; Mitsuji Iwasa; Satoshi Yamakawa; Takuhito Nagai; Nobuaki Takagi; Hiromu Mae; Kenji Iijima; Elena Bresin
Journal:  Clin Exp Nephrol       Date:  2011-01-27       Impact factor: 2.801

2.  Autoantibodies to CD59, CD55, CD46 or CD35 are not associated with atypical haemolytic uraemic syndrome (aHUS).

Authors:  Rachael Watson; Emma Wearmouth; Amy-Claire McLoughlin; Arthur Jackson; Sophie Ward; Paula Bertram; Karim Bennaceur; Catriona E Barker; Isabel Y Pappworth; David Kavanagh; Susan M Lea; John P Atkinson; Timothy H J Goodship; Kevin J Marchbank
Journal:  Mol Immunol       Date:  2014-08-21       Impact factor: 4.407

3.  Combined complement gene mutations in atypical hemolytic uremic syndrome influence clinical phenotype.

Authors:  Elena Bresin; Erica Rurali; Jessica Caprioli; Pilar Sanchez-Corral; Veronique Fremeaux-Bacchi; Santiago Rodriguez de Cordoba; Sheila Pinto; Timothy H J Goodship; Marta Alberti; David Ribes; Elisabetta Valoti; Giuseppe Remuzzi; Marina Noris
Journal:  J Am Soc Nephrol       Date:  2013-02-21       Impact factor: 10.121

4.  Clinical features of anti-factor H autoantibody-associated hemolytic uremic syndrome.

Authors:  Marie-Agnès Dragon-Durey; Sidharth Kumar Sethi; Arvind Bagga; Caroline Blanc; Jacques Blouin; Bruno Ranchin; Jean-Luc André; Nobuaki Takagi; Hae Il Cheong; Pankaj Hari; Moglie Le Quintrec; Patrick Niaudet; Chantal Loirat; Wolf Herman Fridman; Véronique Frémeaux-Bacchi
Journal:  J Am Soc Nephrol       Date:  2010-11-04       Impact factor: 10.121

Review 5.  Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies.

Authors:  Julien Zuber; Fadi Fakhouri; Lubka T Roumenina; Chantal Loirat; Véronique Frémeaux-Bacchi
Journal:  Nat Rev Nephrol       Date:  2012-10-02       Impact factor: 28.314

Review 6.  Primary disease recurrence—effects on paediatric renal transplantation outcomes.

Authors:  Justine Bacchetta; Pierre Cochat
Journal:  Nat Rev Nephrol       Date:  2015-04-28       Impact factor: 28.314

7.  Complement factor H-related protein 1 deficiency and factor H antibodies in pediatric patients with atypical hemolytic uremic syndrome.

Authors:  Johannes Hofer; Andreas R Janecke; L B Zimmerhackl; Magdalena Riedl; Alejandra Rosales; Thomas Giner; Gerard Cortina; Carola J Haindl; Barbara Petzelberger; Miriam Pawlik; Verena Jeller; Udo Vester; Bettina Gadner; Michael van Husen; Michael L Moritz; Reinhard Würzner; Therese Jungraithmayr
Journal:  Clin J Am Soc Nephrol       Date:  2012-12-14       Impact factor: 8.237

Review 8.  aHUS caused by complement dysregulation: new therapies on the horizon.

Authors:  Aoife M Waters; Christoph Licht
Journal:  Pediatr Nephrol       Date:  2010-06-18       Impact factor: 3.714

Review 9.  Anti-complement-factor H-associated glomerulopathies.

Authors:  Marie-Agnes Dragon Durey; Aditi Sinha; Shambhuprasad Kotresh Togarsimalemath; Arvind Bagga
Journal:  Nat Rev Nephrol       Date:  2016-07-25       Impact factor: 28.314

10.  Long-term remission of atypical HUS with anti-factor H antibodies after cyclophosphamide pulses.

Authors:  Gwenaëlle Sana; Marie-Agnès Dragon-Durey; Marina Charbit; Karim Bouchireb; Caroline Rousset-Rouvière; Etienne Bérard; Rémi Salomon; Véronique Frémeaux-Bacchi; Patrick Niaudet; Olivia Boyer
Journal:  Pediatr Nephrol       Date:  2013-07-19       Impact factor: 3.714
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.